Suchergebnisse - "Tavakolpour, Soheil"

PubPharm (28)

1

Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine : A 10-year experience in a skin hospital

enthalten in: International immunopharmacology | 2020

von Nili, A. | Zarei, E. | Ghamari, A. | +4

2

Concomitant bullous pemphigoid and palmoplantar keratoderma : A report of three cases and review of literature

enthalten in: Dermatologic therapy | 2020

von Sadeghi, B. | Nili, A. | Tavakolpour, S. | +3

3

Decreased serum levels of interleukin-17, interleukin-23, TGF-β in pemphigus vulgaris patients, and their association with disease phase

enthalten in: Dermatologic therapy | 2020

von Gholibeigian, Z. | Izad, M. | Daneshpazhooh, M. | +6

4

Transition between pemphigus vulgaris and pemphigus foliaceus : a 10-year follow-up study

enthalten in: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG | 2020

von Mohammadrezaee, M. | Etesami, I. | Mahmoudi, H. | +4

5

Remdesivir : A beacon of hope from Ebola virus disease to COVID-19

enthalten in: Reviews in medical virology | 2020

von Nili, A. | Farbod, A. | Neishabouri, A. | +3

6

Investigating expression pattern of eight immune-related genes in pemphigus patients compared with the healthy controls and after rituximab therapy : Potential roles of CTLA4 and FCGR3A genes expression in outcomes of rituximab therapy

enthalten in: Dermatologic therapy | 2020

von Tavakolpour, S. | Mahmoudi, H. | Karami, F. | +8

7

enthalten in: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG | 2020

von Mohammadrezaee, M. | Etesami, I. | Mahmoudi, H. | +4

8

Treatment of pemphigus patients in the COVID-19 era : A specific focus on rituximab

enthalten in: Dermatologic therapy | 2020

von Mahmoudi, H. | Tavakolpour, S. | Nili, A. | +3

9

Estimated cut-off values for pemphigus severity classification according to pemphigus disease area index (PDAI), autoimmune bullous skin disorder intensity score (ABSIS), and anti-desmoglein 1 autoantibodies

enthalten in: BMC dermatology | 2020

von Mohebi, F. | Tavakolpour, S. | Teimourpour, A. | +11

10

Estimated cut-off values for pemphigus severity classification according to pemphigus disease area index (PDAI), autoimmune bullous skin disorder intensity score (ABSIS), and anti-desmoglein 1 autoantibodies

enthalten in: BMC dermatology | 2020

von Mohebi, F. | Tavakolpour, S. | Teimourpour, A. | +11